INOVIQ Ltd (ASX:IIQ – Get Rating) insider Philip (Phil) Powell acquired 19,481 shares of INOVIQ stock in a transaction dated Friday, March 3rd. The stock was bought at an average price of A$0.56 ($0.38) per share, for a total transaction of A$10,909.36 ($7,321.72).
Philip (Phil) Powell also recently made the following trade(s):
Get
INOVIQ alerts:
- On Monday, March 6th, Philip (Phil) Powell acquired 20,000 shares of INOVIQ stock. The stock was bought at an average price of A$0.57 ($0.38) per share, for a total transaction of A$11,400.00 ($7,651.01).
- On Wednesday, March 1st, Philip (Phil) Powell acquired 18,518 shares of INOVIQ stock. The stock was bought at an average price of A$0.54 ($0.36) per share, for a total transaction of A$9,999.72 ($6,711.22).
INOVIQ Price Performance
The company has a debt-to-equity ratio of 3.73, a current ratio of 5.28 and a quick ratio of 9.52.
INOVIQ Company Profile
(Get Rating)
INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.
Further Reading
- REV Group Hits A Wall Despite Results And Outlook
- Oil Tankers In Buy Range After Breaking Out Of Bases
- United Natural Foods Under Delivered...Did the Market Overreact?
- Can Cricut Stock Jump Higher In 2023?
- 10 Best Consumer Staples ETFs
Receive News & Ratings for INOVIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INOVIQ and related companies with MarketBeat.com's FREE daily email newsletter.
INOVIQ有限公司(ASX:IIQ-GET Rating)內部人士菲利普(Phil)鮑威爾在一筆日期為3月3日星期五的交易中收購了INOVIQ股票19,481股。該股的平均價格為每股0.56澳元(合0.38美元),總成交額為10,909.36澳元(合7,321.72美元)。
菲利普(菲爾)鮑威爾最近還進行了以下交易:
到達
INOVIQ警報:
- 3月6日星期一,菲利普(菲爾)·鮑威爾收購了2萬股INOVIQ股票。該股的收購均價為每股0.57澳元(合0.38美元),總成交金額為11,400.00澳元(合7,651.01美元)。
- 3月1日,星期三,菲利普(菲爾)鮑威爾收購了18,518股INOVIQ股票。該股的平均價格為每股0.54澳元(合0.36美元),總成交額為9,999.72澳元(合6711.22美元)。
INOVIQ性價比
該公司的債務權益比為3.73,流動比率為5.28,速動比率為9.52。
INOVIQ公司簡介
(獲取評級)
INOVIQ有限公司致力於診斷和基於外顯子的產品的研究、開發和商業化,以加強澳大利亞和美國對癌症和其他疾病的診斷和治療。該公司提供hTERT檢測,這是一種免疫細胞化學檢測,用於膀胱癌的尿細胞學檢測;以及EXO-Net,用於捕獲和分離液體活檢樣本中的外切體。
進一步閱讀
- Rev Group不顧業績和前景而碰壁
- 油輪突破基地後進入買入區間
- 聯合天然食品供不應求……市場反應過度了嗎?
- Cricut股價在2023年能跳高嗎?
- 十大最佳消費者必需品ETF
接受INOVIQ日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對INOVIQ和相關公司的最新新聞和分析師評級的每日簡明摘要。